Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR2 | P21452 | 16/20 | 0.51 |
| ▸ | TACR1 | P25103 | 1/20 | 0.45 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.41 |
| ▸ | CCR5 | P51681 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4258295 | 1.00 | TACR2 (0.51) | TACR2TACR1KCNH2CCR5 | |
| SCHEMBL4257153 | 0.94 | TACR2 (0.50) | TACR2TACR1KCNH2CCR5 | |
| SCHEMBL5800599 | 0.94 | TACR2 (0.50) | TACR2TACR1KCNH2CCR5 | |
| SCHEMBL14136097 | 0.94 | TACR2 (0.48) | TACR2TACR1KCNH2CCR5 | |
| SCHEMBL4256226 | 0.91 | TACR2 (0.49) | TACR2TACR1KCNH2 | |
| SCHEMBL4256311 | 0.91 | TACR2 (0.49) | TACR2TACR1KCNH2CCR5 | |
| SCHEMBL4256282 | 0.89 | TACR2 (0.47) | TACR2TACR1KCNH2 | |
| SCHEMBL4262600 | 0.89 | TACR2 (0.66) | TACR2 | |
| SCHEMBL4256227 | 0.89 | TACR2 (0.59) | TACR2TACR1CCR5 | |
| SCHEMBL5800848 | 0.89 | TACR2 (0.66) | TACR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2006062478-A1 | NOVEL TREATMENT OF GASTROINTESTINAL DISORDERS | ASTRAZENECA AB (SE) | 2006-06-15 | — | — | WO | claimed |
| EP-1636221-A2 | NEW AZETIDINE COMPOUNDS | AstraZeneca AB (SE) | 2006-03-22 | — | — | EP | disclosed |
| WO-2004110344-A2 | NEW AZETIDINE COMPOUNDS | ASTRAZENECA AB (SE) | 2004-12-23 | — | — | WO | disclosed |